Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for prevention of postpartum blood loss after vaginal delivery
PACTR202606623312257Not yet recruiting
- Sponsor
- Katsina State Hospitals Services Management Board
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Katsina State Hospitals Services Management Board. Primary endpoint: Measured blood loss from the genital tract within the first 2 hours after vaginal delivery. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202606623312257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606623312257.